Renin-angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: Systematic review and meta-analysis

Renin-angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: Systematic review and meta-analysis

Aims: This meta-analysis provides summary odds ratio (OR) estimates for associations between treatment with (vs. without) renin-angiotensin system blockers and risk of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection and coronavirus disease 2019 (CoViD-19) severity (including c...

Full description

Bibliographic Details
Main Authors: Docherty, K.F (Author), Jhund, P.S (Author), Kalra, A. (Author), Lee, M.M.Y (Author), McMurray, J.J.V (Author), Mehta, N. (Author), Nowacki, A.S (Author), Petrie, M.C (Author), Sattar, N. (Author), Solomon, S.D (Author), Vaduganathan, M. (Author)
Format: Article
Language:English
Published: Oxford University Press 2022
Subjects:
Angi
angiotensin receptor antagonist
Angiotensin Receptor Antagonists
Angiotensin receptor blocker
Angiotensin-Converting Enzyme Inhibitors
COVID-19
dipeptidyl carboxypeptidase inhibitor
human
Humans
meta analysis
Meta-analysis
Otensin-converting enzyme inhibitor
renin angiotensin aldosterone system
Renin-angiotensin system
Renin-Angiotensin System
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items